In a significant boost to the field of neuromedicine, Rapport Therapeutics has successfully raised $150 million in funding to advance its pioneering precision medicine approach for treating neurological disorders. Founded in March 2023 through the synergistic collaboration of Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc., Rapport aims to revolutionize the treatment landscape by specifically targeting disease-driving neurocircuits using receptor-associated proteins (RAPs). This innovative strategy addresses the crucial challenges faced by conventional neuromedicines, which often act indiscriminately across the nervous system, leading to inefficacious outcomes and detrimental side effects. With this latest funding, Rapport Therapeutics is poised to expedite its groundbreaking research and development initiatives, assembling a talented team of science leaders with extensive experience in neuroscience and drug discovery. The capital will enable the company to further its clinical trials, optimize drug formulations, and ultimately bring to market a suite of precision therapies that aim to enhance patient outcomes for those suffering from a range of neurological disorders. Headquartered in San Diego, CA, and Boston, MA, Rapport Therapeutics is on a mission to change the narrative in neurological care, paving the way towards a future where treatment is more effective and personalized. For more information about their groundbreaking work, please visit www.rapportrx.com.
Rapport Therapeutics Secures $150 Million in Series B Funding to Revolutionize Neurological Disorder Treatment
Recently funded · $150.0M Series bPharmaceuticals
Get the full Rapport Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
